good news and bad news about Vioxx
The good news and bad news about Vioxx is creating questions.
GI safety. Vioxx (rofecoxib) reduces the risk of GI bleeding and perforations by 50% compared to naproxen.
Vioxx is the first COX-2 inhibitor with proof acceptable to the FDA that it causes fewer serious ulcers than a traditional NSAID.